Q-omics provides the consensus-scored COPRSP1 profile across patient tissues and cancer cell-line models. COPRSP1 expression is associated with patient survival in 13 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, COPRSP1 is differentially expressed in 4, with the highest sampling consensus in THCA. Additionally, COPRSP1 RNA expression shows 8,900 significant protein co-abundance associations, with the highest sampling consensus in HNSC. Together, these results highlight UVM, THCA, and HNSC as cancer lineages where COPRSP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for COPRSP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes COPRSP1 survival associations across molecular data types. COPRSP1 RNA expression shows survival associations in the most cancer types (13). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible COPRSP1 RNA expression–survival associations across cancer types. High COPRSP1 expression shows unfavorable associations in UVM, HNSC, MESO, ESCA and STAD, but favorable associations in SKCM. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for COPRSP1 RNA expression.
This table summarizes COPRSP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 4. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for COPRSP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. COPRSP1 shows lower tumor expression in THCA and higher tumor expression in COAD, KIRP and LUSC. The THCA box plot shows higher COPRSP1 RNA expression in normal versus tumor tissue (log2 FC = −0.058, t-test p < 0.001).
This table shows molecular features associated with COPRSP1 in patient tissues and cancer cell lines. In patient samples, COPRSP1 shows the broadest associations at the RNA and protein expression levels, with HNSC recurring as the lineage with the largest associated feature set.
